CRISPR-Cas9 technology has revolutionised the field of genome editing and has enabled high efficiency mammalian cell engineering for a variety of downstream applications. The Gene Editing division at OXGENE has developed an automated, streamlined pipeline for the generation of knock-out mammalian cell lines.
Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of qualify control, efficiency and project management available for any client.
OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.
